Translational Research Program

Organization
Leukemia and Lymphoma Society (LLS)
Type
Foundation
LOI Due Date
10-20-2023
Application Due Date
01-19-2024
Brief Description

The Translational Research Program (TRP) was formed to enhance the transfer of basic research findings to clinical usefulness.

We are looking for applications that propose novel approaches to the prevention, diagnosis, or treatment of hematological malignancies and related pre-malignant conditions. Proposals should be based on molecular, cellular, or integrated systems findings and be conceptually innovative and with a clear plan for the eventual clinical translation of the studies proposed and the results expected.